Rabu, 21 Maret 2018

VR MED - The first VR solution in MedTech

Foto VR MED.

Greetings Community,

VR MED Today

VR MED software and hardware complex for screening in the field of Ophthalmology was tested in the Institute of Eye Diseases of the Academy of Sciences Russia and FH Aachen University of applied science, Germany. Today, the VR helmet is capable of replacing 40% of all instrument functionality ophthalmology room, having a cost of 6 times less than the cost equipment "Golden Standard".

Multifunctional Medical headset



Vision Field Analyzer

The VR MED headset provides vision field analysis to allow physicians to diagnosis early-stage glaucoma. Preliminary testing of the headset, completed at the FH Aachen University of Applied Sciences, has confirmed the uniqueness and innovation of this product. Now the equipment is undergoing testing at the Institute of Eye Diseases at the Russian Academy of Sciences.

Portability

The VR MED headset is mobile. To use it, the clinician needs only the headset itself, and the notebook that it will be plugged into. Its weight (0.4 kg, about one pound) and compact dimensions add to its ease of transport. It can be used in mobile medical units, small stationary clinics and with telemedicine set-ups.

Ergonomic Design

VR MED is integrated into a headset with ergonomic design, which, in contrast with its competitors, provides a higher degree of accuracy in rapid-speed eye-tracking. This gives the headset versatility for use in various medical settings.

All you need to produce results: put in the appropriate software and configure the system VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system. There is no need to change the device itself. Just one set of equipment covers a large part of the clinic’s needs with VR technology.

Description of the platform and its necessity for the development of VR MED
Data storage, transport, exchange and sale.
read more

Assistance with development of new software solutions using the headset – approval, testing, market introduction through the internal platform for procurement of investment.
read more

Sales of new successful software solutions to medical centers.
read more

Token Sale
  • About VRMD Token
  • Token
  • ERC 20 Protocol
  • Quantity
  • 24 000 000 Tokens
  • Price
  • 0.25 USD = 1 Token VRMD
  • Buy with
  • BTC   ETH   USD


Investment Attractiveness


VRMD Token is an internal currency platform which allows holders to:

Acquire a product and access to services for a reduced price in comparison to with fiat currency
Acquire access to update software, widen the functional capabilities of the headset, buying and selling data.
Take part in fundraising for new medical developments for the VR MED headset Growth of demand for the tokens will depend on growth of demand for the device and updates.

Gadget Features

VR MED is unique in its functional capabilities. One device contains the power to collect data in more than one sphere of medicine.

Rehabilitation 7.5 bln
The device market volume for rehabilitation measures by 2025 is planned at a level of 17.5 billion US dollars.
Share VR MED can reach up to 15%.

Neurology 10.8 bln
The market volume of devices for neurology by 2022 will amount to $ 10.8 billion. VR MED can potentially up to 20% of the solutions in this area.

Ophthalmology 58 bln
The volume of the ophthalmology market in 2021 will be 58 billion US dollars. The part that will be the VR solution. Currently, VR MED has the potential to occupy about 10% of the market.

Roadmap

Before ICO
Start of the development of VR headset and programming suitable for medical use.

06.2016
Patent granted in Russia.
Start of process to receive international patents

12.16 - 02.17
Creation of pilot model of equipment and software for screening for glaucoma and other conditions with peripheral vision defects.
Successful experimental outcomes in the Institute of Eye Diseases at the Russian Academy of Sciences

02.17 - 04.17
Participation at international presentations in Lisbon and Bahrain. Introduction of the device

04.17
Successful approval process for the device and software at the FH Aachen University of Applied Sciences

05.17-07.17
Development of the Alpha version of the device, with capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers)
07.17-10.17

After ICO
Start of the development of VR headset and programming suitable for medical use.

06.2016
Patent granted in Russia.
Start of process to receive international patents

12.16 - 02.17
Creation of pilot model of equipment and software for screening for glaucoma and other conditions with peripheral vision defects.
Successful experimental outcomes in the Institute of Eye Diseases at the Russian Academy of Sciences

02.17 - 04.17
Participation at international presentations in Lisbon and Bahrain. Introduction of the device

04.17
Successful approval process for the device and software at the FH Aachen University of Applied Sciences

05.17-07.17
Development of the Alpha version of the device, with capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers)
07.17-10.17

Development of the device final version
(technical and usage fine-tuning), construct improvements

03.18 - 06.18
Standard ISO 12866-2011. Industrial design development

06.18 - 08.18
Certification of software "Perimeter": Creation of a universal design for the diagnosis of a range of visual functions (through early diagnosis of glaucoma and other peripheral vision field defects)

08.18 - 12.18
Entrance to the world market: Undergo approval process in India and China clinics; obtain international ISO certification

04.18 - 09.18
Upload of users' data to the platform. Distribution of the device in the European Union, Russia and Asia;
Launch of decentralized platform;
The 100% functional Perimeter becomes the "gold standard" in ophthalmic diagnosis

05.18 - 07.19
Widening of device functionality to include usage in neurology and rehabilitation
05.18 - 07.19

For More Information:


Bitcointalk username :Aray80

Featured post

IMUSIFY - Giving Higher Autonomy Income Artists

Hello everyone, If you are interested in joining the Imusify project, it is a good idea to read reviews that can help you get informati...